51.79
Qiagen Nv Borsa (QGEN) Ultime notizie
What analysts say about Qiagen N.V. stockOutstanding trading profits - PrintWeekIndia
Qiagen Announces BlackRock’s Significant Voting Rights - TipRanks
Is Qiagen N.V. a good long term investmentLightning-fast capital gains - PrintWeekIndia
What drives Qiagen N.V. stock priceFree Investment Portfolio Suggestions - PrintWeekIndia
Qiagen (QGEN) Sees Price Target Raised by Berenberg Analyst | QGEN Stock News - GuruFocus
Qiagen N.V.'s (NYSE:QGEN) high institutional ownership speaks for itself as stock continues to impress, up 4.3% over last week - Yahoo Finance
Berenberg raises Qiagen stock price target to EUR50 on growth pillars - Investing.com Australia
Berenberg raises Qiagen stock price target to EUR50 on growth pillars By Investing.com - Investing.com South Africa
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - BioSpace
BlackRock Discloses Significant Stake in Qiagen - AInvest
BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks
Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks
QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com
Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛
Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo.co
Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen and Gencurix partner for oncology tests - MSN
Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa
QIAGEN Announces Managerial Share Transaction - TipRanks
Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):